Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Litvan

Showing results (221-230 of 331) with videos related to

Pageof 34
Sort By:
Alzheimer Disease and Associated Disorders|August 24, 2023
Predictors of Cognitive Change in Parkinson Disease: A 2-year Follow-up StudyCarmen Gasca-Salas, Sarah Duff-Canning, Eric McArthur, et al.
Journal of Neuropathology and Experimental Neurology|May 8, 2007
The etiopathogenesis of Parkinson disease and suggestions for future research. Part IIIrene Litvan, Marie-Francoise Chesselet, Thomas Gasser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 2, 2007
Clinical diagnostic criteria for dementia associated with Parkinson's diseaseMurat Emre, Dag Aarsland, Richard Brown, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 19, 2025
Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodiesJennifer G Goldman, Bradley F Boeve, Douglas Galasko, et al.
Movement Disorders Clinical Practice|September 3, 2025
Progressive Supranuclear Palsy-A Global ReviewPrashanth Lingappa Kukkle, Rosy Neupane, Alexandar Pantelyat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 16, 2025
Performance of <sup>123</sup>I-ioflupane SPECT striatal binding in dementia with Lewy bodiesEmily F Maly, Frank P DiFilippo, Brittany Lapin, et al.
Nature Medicine|August 13, 2021
Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialTien Dam, Adam L Boxer, Lawrence I Golbe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 23, 2013
Measuring mild cognitive impairment in patients with Parkinson's diseaseConnie Marras, Melissa J Armstrong, Christopher A Meaney, et al.
Neurology|November 17, 2025
CSF α-Synuclein Seed Amplification Assays and Alzheimer Disease Biomarkers in Dementia With Lewy Bodies: Presentation and ProgressionDavid G Coughlin, Lavanya Jain, Maria Khrestian, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 19, 2025
Language impairment is associated with faster progression in progressive supranuclear palsy-Richardson syndromeIndira Garcia-Cordero, Juan Camilo Vargas-Gonzalez, Mohsen Hadian, et al.
Pageof 34

Showing results (221-230 of 331) with videos related to

Sort By:
Pageof 34
Alzheimer Disease and Associated Disorders|August 24, 2023
Predictors of Cognitive Change in Parkinson Disease: A 2-year Follow-up StudyCarmen Gasca-Salas, Sarah Duff-Canning, Eric McArthur, et al.
Journal of Neuropathology and Experimental Neurology|May 8, 2007
The etiopathogenesis of Parkinson disease and suggestions for future research. Part IIIrene Litvan, Marie-Francoise Chesselet, Thomas Gasser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 2, 2007
Clinical diagnostic criteria for dementia associated with Parkinson's diseaseMurat Emre, Dag Aarsland, Richard Brown, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 19, 2025
Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodiesJennifer G Goldman, Bradley F Boeve, Douglas Galasko, et al.
Movement Disorders Clinical Practice|September 3, 2025
Progressive Supranuclear Palsy-A Global ReviewPrashanth Lingappa Kukkle, Rosy Neupane, Alexandar Pantelyat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 16, 2025
Performance of <sup>123</sup>I-ioflupane SPECT striatal binding in dementia with Lewy bodiesEmily F Maly, Frank P DiFilippo, Brittany Lapin, et al.
Nature Medicine|August 13, 2021
Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialTien Dam, Adam L Boxer, Lawrence I Golbe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 23, 2013
Measuring mild cognitive impairment in patients with Parkinson's diseaseConnie Marras, Melissa J Armstrong, Christopher A Meaney, et al.
Neurology|November 17, 2025
CSF α-Synuclein Seed Amplification Assays and Alzheimer Disease Biomarkers in Dementia With Lewy Bodies: Presentation and ProgressionDavid G Coughlin, Lavanya Jain, Maria Khrestian, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 19, 2025
Language impairment is associated with faster progression in progressive supranuclear palsy-Richardson syndromeIndira Garcia-Cordero, Juan Camilo Vargas-Gonzalez, Mohsen Hadian, et al.
Pageof 34